Lilly Says Court Ruled in its Favor on Patent

Eli Lilly & Co. said a federal court ruled that generic products proposed by a Teva Pharmaceutical Industries Ltd. unit would infringe a U.S. patent for the drug maker’s blockbuster cancer drug Alimta.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news